These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2278761)

  • 41. A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine.
    Black S; Greenberg DP
    Expert Rev Vaccines; 2005 Dec; 4(6):793-805. PubMed ID: 16372875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Vaccination status of children in the Vienna area (author's transl)].
    Kessler T
    Wien Klin Wochenschr; 1978 Dec; 90(23):835-8. PubMed ID: 741751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IMMUNIZATION 1964.
    SCHWARZ K
    Nurs Times; 1964 Oct; 60():1315-6. PubMed ID: 14230263
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.
    Dominicus R; Galtier F; Richard P; Baudin M
    Vaccine; 2014 Jun; 32(31):3942-9. PubMed ID: 24852717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Adverse events following immunization: AEFI in 17 children between 0 and 2 years of age].
    Taraszkiewicz F; Bogus-Parafieniuk W; Ołdak E; Sulik A
    Przegl Epidemiol; 1994; 48(4):505-9. PubMed ID: 7597191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Current problems of vaccination].
    Grahneis H
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):510-6. PubMed ID: 4398882
    [No Abstract]   [Full Text] [Related]  

  • 49. [Recurrence of febrile convulsions after the first diphtheria-pertussis-tetanus vaccination and measles vaccination in children with febrile convulsions: a questionnaire survey in Takamatsu City].
    Miyake S; Fujita M; Endo C; Taoka N; Kuzuhara M
    No To Hattatsu; 2001 Jul; 33(4):336-41. PubMed ID: 11494577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines.
    Rosen JB; Breman JG; Manclark CR; Meade BD; Collins WE; Lobel HO; Saliou P; Roberts JM; Campaoré P; Miller MA
    Malar J; 2005 Nov; 4():53. PubMed ID: 16271153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
    Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A 10-year review of morbidity from childhood preventable diseases in Nigeria: how successful is the Expanded Programme of Immunization (EPI)?
    Ekanem EE
    J Trop Pediatr; 1988 Dec; 34(6):323-8. PubMed ID: 3221418
    [No Abstract]   [Full Text] [Related]  

  • 53. Vaccinations in the health strategies of developing countries.
    Henderson RH
    Scand J Infect Dis Suppl; 1990; 76():7-14. PubMed ID: 2102022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization].
    Miura S
    Nihon Shonika Gakkai Zasshi; 1968 Jun; 72(6):767-81. PubMed ID: 5749510
    [No Abstract]   [Full Text] [Related]  

  • 55. Vaccination coverage in Northern Province, Papua New Guinea.
    Mirou P; Masere D
    P N G Med J; 1983 Jun; 26(2):99-101. PubMed ID: 6593968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccinated versus unvaccinated children: how they fare in first five years of life.
    Epoke J; Eko F; Mboto CI
    Trop Geogr Med; 1990 Apr; 42(2):182-4. PubMed ID: 2260220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical studies on efficacy and safety of acellular pertussis vaccine.
    Isomura S
    Tokai J Exp Clin Med; 1988; 13 Suppl():39-43. PubMed ID: 3078809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccination coverage of 2-year-old children--United States, 1992-1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Apr; 43(15):282-3. PubMed ID: 8164635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Private pediatric practice: performance and problems.
    Starfield B; Seidel H; Carter G; Garvin W; Seddon J
    Pediatrics; 1973 Sep; 52(3):344-51. PubMed ID: 4730391
    [No Abstract]   [Full Text] [Related]  

  • 60. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps.
    Smorodintsev AA; Nasibov MN; Jakovleva NV
    Bull World Health Organ; 1970; 42(2):283-9. PubMed ID: 5310140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.